Glen Harbor Capital Management’s ResMed RMD Stock Holding History

Glen Harbor Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$404K	Sell	2,992 -544	-15%	-$71.3K	0.01%	774
2019 Q2	$431K	Sell	3,536 -672	-16%	-$74.4K	0.01%	756
2019 Q1	$438K	Buy	4,208 +1,168	+38%	+$121K	0.01%	725
2018 Q4	$346K	Sell	3,040 -512	-14%	-$54.9K	0.01%	747
2018 Q3	$410K	Sell	3,552 -80	-2%	-$8.76K	0.01%	799
2018 Q2	$376K	Buy	3,632 +112	+3%	+$11.3K	0.01%	750
2018 Q1	$347K	Sell	3,520 -256	-7%	-$24.2K	0.01%	771
2017 Q4	$320K	Buy	3,776 +288	+8%	+$23.8K	0.01%	809
2017 Q3	$268K	Sell	3,488 -4,800	-58%	-$367K	0.01%	801
2017 Q2	$645K	Buy	8,288 +2,560	+45%	+$183K	0.02%	515
2017 Q1	$412K	Sell	5,728 -1,776	-24%	-$123K	0.01%	603
2016 Q4	$466K	Buy	+7,504	New	+$460K	0.01%	524

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Glen Harbor Capital Management's RMD Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its ResMed (RMD) stake by 15% in Q3 2019, selling an estimated $71.3K and leaving 2,992 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #774.

Glen Harbor Capital Management first reported a position in RMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $645K in Q2 2017. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

Glen Harbor Capital Management held 2,992 shares of ResMed worth $404K as of Q3 2019.
Glen Harbor Capital Management sold 544 ResMed shares in Q3 2019, an estimated $71.3K.
ResMed made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #774 holding.
Glen Harbor Capital Management first reported a position in ResMed in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's ResMed position peaked at $645K in Q2 2017.
528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.